BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 32889242)

  • 1. The role of macrophages in pulmonary hypertension: Pathogenesis and targeting.
    Chen S; Yan D; Qiu A
    Int Immunopharmacol; 2020 Nov; 88():106934. PubMed ID: 32889242
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Origin and production of inflammatory perivascular macrophages in pulmonary hypertension.
    Florentin J; Dutta P
    Cytokine; 2017 Dec; 100():11-15. PubMed ID: 28855075
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Macrophage Immunomodulation: The Gatekeeper for Mesenchymal Stem Cell Derived-Exosomes in Pulmonary Arterial Hypertension?
    Willis GR; Fernandez-Gonzalez A; Reis M; Mitsialis SA; Kourembanas S
    Int J Mol Sci; 2018 Aug; 19(9):. PubMed ID: 30150544
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A Time- and Compartment-Specific Activation of Lung Macrophages in Hypoxic Pulmonary Hypertension.
    Pugliese SC; Kumar S; Janssen WJ; Graham BB; Frid MG; Riddle SR; El Kasmi KC; Stenmark KR
    J Immunol; 2017 Jun; 198(12):4802-4812. PubMed ID: 28500078
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nonclassical Monocytes Sense Hypoxia, Regulate Pulmonary Vascular Remodeling, and Promote Pulmonary Hypertension.
    Yu YA; Malakhau Y; Yu CA; Phelan SJ; Cumming RI; Kan MJ; Mao L; Rajagopal S; Piantadosi CA; Gunn MD
    J Immunol; 2020 Mar; 204(6):1474-1485. PubMed ID: 31996456
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The role of immune cells in pulmonary hypertension: Focusing on macrophages.
    Luo P; Qiu B
    Hum Immunol; 2022 Feb; 83(2):153-163. PubMed ID: 34844784
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inflammation, immunological reaction and role of infection in pulmonary hypertension.
    Pullamsetti SS; Savai R; Janssen W; Dahal BK; Seeger W; Grimminger F; Ghofrani HA; Weissmann N; Schermuly RT
    Clin Microbiol Infect; 2011 Jan; 17(1):7-14. PubMed ID: 20545963
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inflammatory Macrophage Expansion in Pulmonary Hypertension Depends upon Mobilization of Blood-Borne Monocytes.
    Florentin J; Coppin E; Vasamsetti SB; Zhao J; Tai YY; Tang Y; Zhang Y; Watson A; Sembrat J; Rojas M; Vargas SO; Chan SY; Dutta P
    J Immunol; 2018 May; 200(10):3612-3625. PubMed ID: 29632145
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lung cancer-associated pulmonary hypertension: Role of microenvironmental inflammation based on tumor cell-immune cell cross-talk.
    Pullamsetti SS; Kojonazarov B; Storn S; Gall H; Salazar Y; Wolf J; Weigert A; El-Nikhely N; Ghofrani HA; Krombach GA; Fink L; Gattenlöhner S; Rapp UR; Schermuly RT; Grimminger F; Seeger W; Savai R
    Sci Transl Med; 2017 Nov; 9(416):. PubMed ID: 29141888
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Key inflammatory pathways underlying vascular remodeling in pulmonary hypertension.
    Berghausen EM; Feik L; Zierden M; Vantler M; Rosenkranz S
    Herz; 2019 Apr; 44(2):130-137. PubMed ID: 30847510
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Causal Role of IL-4 and IL-13 in Schistosoma mansoni Pulmonary Hypertension.
    Kumar R; Mickael C; Chabon J; Gebreab L; Rutebemberwa A; Garcia AR; Koyanagi DE; Sanders L; Gandjeva A; Kearns MT; Barthel L; Janssen WJ; Mauad T; Bandeira A; Schmidt E; Tuder RM; Graham BB
    Am J Respir Crit Care Med; 2015 Oct; 192(8):998-1008. PubMed ID: 26192556
    [TBL] [Abstract][Full Text] [Related]  

  • 12. RELMα Licenses Macrophages for Damage-Associated Molecular Pattern Activation to Instigate Pulmonary Vascular Remodeling.
    Lin Q; Fan C; Skinner JT; Hunter EN; Macdonald AA; Illei PB; Yamaji-Kegan K; Johns RA
    J Immunol; 2019 Dec; 203(11):2862-2871. PubMed ID: 31611261
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Anti-monocyte chemoattractant protein-1 gene therapy attenuates pulmonary hypertension in rats.
    Ikeda Y; Yonemitsu Y; Kataoka C; Kitamoto S; Yamaoka T; Nishida K; Takeshita A; Egashira K; Sueishi K
    Am J Physiol Heart Circ Physiol; 2002 Nov; 283(5):H2021-8. PubMed ID: 12384481
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Central role of T helper 17 cells in chronic hypoxia-induced pulmonary hypertension.
    Maston LD; Jones DT; Giermakowska W; Howard TA; Cannon JL; Wang W; Wei Y; Xuan W; Resta TC; Gonzalez Bosc LV
    Am J Physiol Lung Cell Mol Physiol; 2017 May; 312(5):L609-L624. PubMed ID: 28213473
    [TBL] [Abstract][Full Text] [Related]  

  • 15. DNGR1-Cre-mediated Deletion of
    Koudstaal T; van Hulst JAC; Das T; Neys SFH; Merkus D; Bergen IM; de Raaf MA; Bogaard HJ; Boon L; van Loo G; Aerts JGJV; Boomars KA; Kool M; Hendriks RW
    Am J Respir Cell Mol Biol; 2020 Nov; 63(5):665-680. PubMed ID: 32755457
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inflammation and immunity in the pathogenesis of pulmonary arterial hypertension.
    Rabinovitch M; Guignabert C; Humbert M; Nicolls MR
    Circ Res; 2014 Jun; 115(1):165-75. PubMed ID: 24951765
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Roles for the CX3CL1/CX3CR1 and CCL2/CCR2 Chemokine Systems in Hypoxic Pulmonary Hypertension.
    Amsellem V; Abid S; Poupel L; Parpaleix A; Rodero M; Gary-Bobo G; Latiri M; Dubois-Rande JL; Lipskaia L; Combadiere C; Adnot S
    Am J Respir Cell Mol Biol; 2017 May; 56(5):597-608. PubMed ID: 28125278
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Murine Model of Pulmonary Artery Overflow Vasculopathy Revealed Macrophage Accumulation in the Lung.
    Minatsuki S; Takeda N; Soma K; Katoh M; Maki H; Hatano M; Takimoto E; Manabe I; Komuro I
    Int Heart J; 2019 Mar; 60(2):451-456. PubMed ID: 30799373
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Upregulation of Human Endogenous Retrovirus-K Is Linked to Immunity and Inflammation in Pulmonary Arterial Hypertension.
    Saito T; Miyagawa K; Chen SY; Tamosiuniene R; Wang L; Sharpe O; Samayoa E; Harada D; Moonen JAJ; Cao A; Chen PI; Hennigs JK; Gu M; Li CG; Leib RD; Li D; Adams CM; Del Rosario PA; Bill M; Haddad F; Montoya JG; Robinson WH; Fantl WJ; Nolan GP; Zamanian RT; Nicolls MR; Chiu CY; Ariza ME; Rabinovitch M
    Circulation; 2017 Nov; 136(20):1920-1935. PubMed ID: 28935667
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neutralization of CXCL12 attenuates established pulmonary hypertension in rats.
    Bordenave J; Thuillet R; Tu L; Phan C; Cumont A; Marsol C; Huertas A; Savale L; Hibert M; Galzi JL; Bonnet D; Humbert M; Frossard N; Guignabert C
    Cardiovasc Res; 2020 Mar; 116(3):686-697. PubMed ID: 31173066
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.